Cannim

Cannim is a pioneering pharmaceutical manufacturer dedicated to enhancing patient wellbeing through curated cannabinoid medicines and tech-enabled scientific research. Operating within a world-class care ecosystem, Cannim delivers a continuum of care from seed to patient, improving outcomes through evidence-based therapies. Cannim's global community of experts, innovators, academics, healthcare providers, and partner organizations collaborate to co-design impactful solutions.

With an expanding portfolio of plant-medicines hand-selected from premium cultivators worldwide, Cannim serves medical markets in Australia, the UK, EU, and North America. Supported by expert teams in Canada, Australia, the UK, and the USA, Cannim ensures healthcare practitioners have access to consistent, expertly curated formulations tailored to patient needs. Cannim is setting a new standard in patient-centered care.

Located in Sydney, AU, Cannim is committed to delivering inclusive, accessible, and affordable care through research, education, and a range of plant-based and holistic therapies. Cannim is dedicated to continued growth and innovation in the pharmaceutical sector. We invite the manager of Cannim to create a customized and exclusive company showcase and product listing on our platform.